In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $7.03 in the prior trading day, Wave Life Sciences Ltd (NASDAQ: WVE) closed at $7.02, down -0.14%. In other words, the price has decreased by -$0.14 from its previous closing price. On the day, 1.02 million shares were traded. WVE stock price reached its highest trading level at $7.1 during the session, while it also had its lowest trading level at $6.91.
Ratios:
Our goal is to gain a better understanding of WVE by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.56 and its Current Ratio is at 2.56. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on August 04, 2025, initiated with a Buy rating and assigned the stock a target price of $19.
On July 28, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $24.
On July 16, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $16.Citigroup initiated its Buy rating on July 16, 2025, with a $16 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 22 ’25 when Verdine Gregory L. sold 10,000 shares for $10.00 per share. The transaction valued at 100,000 led to the insider holds 285,217 shares of the business.
BOLNO PAUL sold 217,351 shares of WVE for $2,194,810 on Aug 22 ’25. The President and CEO now owns 121,000 shares after completing the transaction at $10.10 per share. On Aug 22 ’25, another insider, PAUL BOLNO, who serves as the Director of the company, bought 217,351 shares for $9.76 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WVE now has a Market Capitalization of 1117773952 and an Enterprise Value of 938270016. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.89 while its Price-to-Book (P/B) ratio in mrq is 7.85. Its current Enterprise Value per Revenue stands at 9.987 whereas that against EBITDA is -6.706.
Stock Price History:
The Beta on a monthly basis for WVE is -1.45, which has changed by -0.16527945 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, WVE has reached a high of $16.74, while it has fallen to a 52-week low of $5.28. The 50-Day Moving Average of the stock is -14.43%, while the 200-Day Moving Average is calculated to be -20.06%.
Shares Statistics:
The stock has traded on average 1.91M shares per day over the past 3-months and 1853150 shares per day over the last 10 days, according to various share statistics. A total of 155.67M shares are outstanding, with a floating share count of 127.19M. Insiders hold about 20.08% of the company’s shares, while institutions hold 83.54% stake in the company. Shares short for WVE as of 1757894400 were 18043501 with a Short Ratio of 9.44, compared to 1755216000 on 16752906. Therefore, it implies a Short% of Shares Outstanding of 18043501 and a Short% of Float of 15.329999999999998.
Earnings Estimates
A detailed examination of Wave Life Sciences Ltd (WVE) is currently in progress, with 12.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.06 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$0.92 and -$1.42 for the fiscal current year, implying an average EPS of -$1.15. EPS for the following year is -$1.18, with 12.0 analysts recommending between -$0.75 and -$1.77.
Revenue Estimates
A total of 14 analysts have provided revenue estimates for WVE’s current fiscal year. The highest revenue estimate was $85M, while the lowest revenue estimate was $17.9M, resulting in an average revenue estimate of $46.79M. In the same quarter a year ago, actual revenue was $108.3M
